Cancer of unknown primary is associated with diabetes

European Journal of Cancer Prevention

Volumn 25, Issue 3, 2016, Pages 246-251

  Hemminki, Kari ^a,b   Försti, Asta ^a,b   Sundquist, Kristina ^b,c   Li, Xinjun ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b LUND UNIVERSITY   (Sweden)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Diabetes; Liver metastases; Metastatic cancer; Type 2 diabetes

Indexed keywords

INSULIN;

ADULT; AGED; ARTICLE; CANCER OF UNKNOWN PRIMARY SITE; CANCER PROGNOSIS; CANCER REGISTRY; DIABETES MELLITUS; FEMALE; HEALTH CARE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; METASTASIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RESPIRATORY SYSTEM; RISK FACTOR; SQUAMOUS CELL CARCINOMA; STANDARDIZED INCIDENCE RATIO; DIABETES COMPLICATIONS; FOLLOW UP; INCIDENCE; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; PATHOPHYSIOLOGY; PROGNOSIS; REGISTER; SWEDEN;

ADULT; AGED; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS, UNKNOWN PRIMARY; PROGNOSIS; REGISTRIES; RISK FACTORS; SWEDEN;

EID: 84962124102     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0000000000000165     Document Type: Article

References (27)

1. Adeghate E, Schattner P, Dunn E (2006). An update on the etiology and epidemiology of diabetes mellitus. Ann N Y Acad Sci 1084:1-29.
2. Anwar WA, Khyatti M, Hemminki K (2014). Consanguinity and genetic diseases in North Africa and immigrants to Europe. Eur J Public Health 24(Suppl 1):57-63.
3. Atchison EA, Gridley G, Carreon JD, Leitzmann MF, McGlynn KA (2011). Risk of cancer in a large cohort of U. S. veterans with diabetes. Int J Cancer 128:635-643.
4. Bevier M, Sundquist J, Hemminki K (2012). Incidence of cancer of unknown primary in Sweden: analysis by location of metastasis. Eur J Cancer Prev 21:596-601.
5. Brewster DH, Lang J, Bhatti LA, Thomson CS, Oien KA (2014). Descriptive epidemiology of cancer of unknown primary site in Scotland, 1961-2010. Cancer Epidemiol 38:227-234.
6. Brustugun OT, Helland Å (2014). Rapid reduction in the incidence of cancer of unknown primary. A population-based study. Acta Oncol 53:134-137.
7. Center for Epidemiology (2010). Cancer incidence in Sweden 2009. Stockholm: The National Board of Health and Welfare. Available at: http://www.sos.se. [Accessed January 2015].
8. Centre for Epidemiology (2013). Cancer incidence in Sweden 2012. Stockholm: The National Board of Health and Welfare. Available at: http://www.sos.se. [Accessed January 2015].
9. Hemminki K, Li X, Sundquist J, Sundquist K (2010). Risk of cancer following hospitalization for type 2 diabetes. Oncologist 15:548-555.
10. Hemminki K, Bevier M, Hemminki A, Sundquist J (2012a). Survival in cancer of unknown primary site: population-based analysis by site and histology. Ann Oncol 23:1854-1863.
11. Hemminki K, Houlston R, Sundquist J, Sundquist K, Shu X (2012b). Co-morbidity between early-onset leukemia and type 1 diabetes - suggestive of a shared viral etiology? PLoS One 7:e39523.
12. Hemminki K, Riihimäki M, Sundquist K, Hemminki A (2013). Site-specific survival rates for cancer of unknown primary according to location of metastases. Int J Cancer 133:182-189.
13. Hemminki K, Chen B, Melander O, Manjer J, Hallmans G, Hemminki A (2015). Smoking and body mass index as risk factors for subtypes of cancer of unknown primary. Int J Cancer 136:246-247.
14. Hussain A, Claussen B, Ramachandran A, Williams R (2007). Prevention of type 2 diabetes: a review. Diabetes Res Clin Pract 76:317-326.
15. Ji J, Sundquist K, Sundquist J, Hemminki K (2012). Comparability of cancer identification among Death Registry, Cancer Registry and Hospital Discharge Registry. Int J Cancer 131:2085-2093.
16. Kaaks R, Sookthai D, Hemminki K, Krämer A, Boeing H, Wirfält E, et al. (2014). Risk factors for cancers of unknown primary site (CUP) - results from the prospective EPIC cohort. Int J Cancer 135:2475-2481.
17. Liu X, Hemminki K, Försti A, Sundquist K, Sundquist J, Ji J (2015). Cancer risk in patients with type 2 diabetes mellitus and their relatives. Int J Cancer (in Press).
18. Mollazadegan K, Fored M, Lundberg S, Ludvigsson J, Ekbom A, Montgomery SM, Ludvigsson JF (2014). Risk of renal disease in patients with both type 1 diabetes and coeliac disease. Diabetologia 57:1339-1345.
19. Pavlidis N, Pentheroudakis G (2012). Cancer of unknown primary site. Lancet 379:1428-1435.
20. Randén M, Rutqvist LE, Johansson H (2009). Cancer patients without a known primary: incidence and survival trends in Sweden 1960-2007. Acta Oncol 48:915-920.
21. Riihimäki M, Hemminki A, Sundquist K, Hemminki K (2013). Time trends in survival from cancer of unknown primary: small steps forward. Eur J Cancer 49:2403-2410.
22. Ringborg A, Martinell M, Stålhammar J, Yin DD, Lindgren P (2008). Resource use and costs of type 2 diabetes in Sweden - estimates from population-based register data. Int J Clin Pract 62:708-716.
23. Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, et al. (2011). Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364:829-841.
24. Shu X, Ji J, Li X, Sundquist J, Sundquist K, Hemminki K (2010). Cancer risk among patients hospitalized for Type 1 diabetes mellitus: a population-based cohort study in Sweden. Diabet Med 27:791-797.
25. Shu X, Sundquist K, Sundquist J, Hemminki K (2012). Time trends in incidence, causes of death, and survival of cancer of unknown primary in Sweden. Eur J Cancer Prev 21:281-288.
26. Van Dieren S, Beulens JW, van der Schouw YT, Grobbee DE, Neal B (2010). The global burden of diabetes and its complications: an emerging pandemic. Eur J Cardiovasc Prev Rehabil 17(Suppl 1):S3-S8.
27. Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R (2009). Diabetes and cancer. Endocr Relat Cancer 16:1103-1123.